Glial fibrillary acidic protein as a biomarker for brain injury in neonatal CHD
- 20 January 2016
- journal article
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 26 (7) , 1282-1289
Abstract
Neonates with critical CHD have evidence, by imaging, of preoperative brain injury, although the timing is unknown. We used circulating postnatal serum glial fibrillary acidic protein as a measure of acute perinatal brain injury in neonates with CHD. Glial fibrillary acidic protein was measured on admission and daily for the first 4 days of life in case and control groups; we included two control groups in this study – non-brain-injured newborns and brain-injured newborns. Comparisons were performed using the Kruskal–Wallis test with Dunn’s multiple comparisons, Student’s t-test, and χ2 test of independence where appropriate. In aggregate, there were no significant differences in overall glial fibrillary acidic protein levels between CHD patients (n=56) and negative controls (n=23) at any time point. By day 4 of life, 7/56 (12.5%) CHD versus 0/23 (0%) normal controls had detectable glial fibrillary acidic protein levels. Although not statistically significant, the 5/10 (50%) left heart obstruction group versus 1/17 (6%) conoventricular, 0/13 (0%) right heart, and 1/6 (17%) septal defect patients trended towards elevated levels of glial fibrillary acidic protein at day 4 of life. Overall, glial fibrillary acidic protein reflected no evidence for significant peripartum brain injury in neonates with CHD, but there was a trend for elevation by postnatal day 4 in neonates with left heart obstruction. This pilot study suggests that methods such as monitoring glial fibrillary acidic protein levels may provide new tools to optimise preoperative care and neuroprotection in high-risk neonates with specific types of CHD.Keywords
This publication has 21 references indexed in Scilit:
- Physical and neurodevelopmental outcomes in children with single-ventricle circulationArchives of Disease in Childhood, 2014
- Glial fibrillary acidic protein as a biomarker for neonatal hypoxic-ischemic encephalopathy treated with whole-body coolingAmerican Journal of Obstetrics and Gynecology, 2011
- Brain Maturity and Brain Injury in Newborns With Cyanotic Congenital Heart DiseasePediatric Cardiology, 2010
- Neurodevelopmental Outcomes in Infants after Surgery for Congenital Heart Disease: A Comparison of Single-Ventricle vs. Two-Ventricle PhysiologyCongenital Heart Disease, 2010
- Brain immaturity is associated with brain injury before and after neonatal cardiac surgery with high-flow bypass and cerebral oxygenation monitoringThe Journal of Thoracic and Cardiovascular Surgery, 2010
- Congenital heart disease and brain developmentAnnals of the New York Academy of Sciences, 2010
- Glial Fibrillary Acidic Protein is Highly Correlated With Brain InjuryJournal of Trauma: Injury, Infection & Critical Care, 2008
- Neurodevelopmental Outcome of Children With Intrauterine Growth Retardation: A Longitudinal, 10-Year Prospective StudyJournal of Child Neurology, 2007
- GFAP Versus S100B in Serum after Traumatic Brain Injury: Relationship to Brain Damage and OutcomeJournal of Neurotrauma, 2004
- The cephalization index: A screening device for brain maturity and vulnerability in normal and intrauterine growth retarded newbornsBrain and Development, 1985